☆ 4.7 Letter

Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS):: high tolerability of daily oral melatonin administration in ALS patients

JOURNAL OF PINEAL RESEARCH (2002)

Get Full Text
Add to Collection

Journal

JOURNAL OF PINEAL RESEARCH
Volume 33, Issue 3, Pages 186-187

Publisher

WILEY-BLACKWELL
DOI: 10.1034/j.1600-079X.2002.02943.x

Keywords

-

Categories

Endocrinology & Metabolism Neurosciences Physiology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.